antibody-drug conjugate

AstraZeneca steps out from Daiichi's shadow, posting data on in-house rivals to AbbVie and Pfizer ADCs
Fierce Biotech
Sun, 09/15/24 - 06:25 pm
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Exelixis drops tissue factor-targeting ADC after deciding it's no match for Tivdak
Fierce Biotech
Wed, 08/7/24 - 11:19 am
Exelixis
antibody-drug conjugate
tissue factor
XB002
Tivdak
Pfizer
Genmab
Ipsen licences second ADC via $1B bet on Foreseen Bio asset
First Word Pharma
Thu, 07/11/24 - 11:22 am
Ipsen
antibody-drug conjugate
FS001
Forseen Biotechnology
Myricx Bio Raises $115M in Series A to Advance ADC With Lilly and Novo Backing
BioSpace
Mon, 07/8/24 - 11:01 pm
Myricx Bio
funding
antibody-drug conjugate
Eli Lilly
BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival
Fierce Biotech
Mon, 07/1/24 - 11:29 am
Bristol Myers Squibb
Eisai
antibody-drug conjugate
FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug
Reuters
Thu, 06/27/24 - 11:18 am
Merck
Daiichi Sankyo
cancer
FDA
patritumab deruxtecan
antibody-drug conjugate
Day One inks $1.2B biobucks pact for MabCare’s solid tumor ADC
Fierce Biotech
Tue, 06/18/24 - 11:45 am
Day One Biopharmaceuticals
MabCare Therapeutics
solid tumors
antibody-drug conjugate
DAY301
BioNTech pays $25M upfront to strengthen ADC bond with China's MediLink
Fierce Biotech
Tue, 05/28/24 - 10:44 am
BioNTech
MediLink Therapeutics
China
antibody-drug conjugate
Pheon rides wave of ADC interest with $120M financing
BioPharma Dive
Tue, 05/21/24 - 11:10 am
Pheon
funding
venture capital
antibody-drug conjugate
Five Deaths in Prostate Cancer Trial Send MacroGenics’ Stock Plummeting
BioSpace
Fri, 05/10/24 - 11:16 am
Macrogenics
clinical trials
antibody-drug conjugate
vobramitamab duocarmazine
prostate cancer
patient deaths
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
antibody-drug conjugate
Immunogen
AbbVie
Seagen
Pfizer
cancer
M&A
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sun, 04/14/24 - 01:27 pm
Merck
M&A
Abceutics
antibody-drug conjugate
AACR: Merck, Kelun’s Anti-TROP2 ADC Shows Early Promise in Gastric Cancer
BioSpace
Wed, 04/10/24 - 09:59 am
Merck
Kelun-Biotech
SKB264
gastric cancer
antibody-drug conjugate
clinical trials
AACR
Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic
Fierce Biotech
Wed, 04/10/24 - 09:52 am
Bristol Myers Squibb
TORL BioTherapeutics
antibody-drug conjugate
funding
The Next Wave of ADCs Could Treat Evasive Solid Tumors
BioSpace
Mon, 04/8/24 - 11:57 am
antibody-drug conjugate
AACR
solid tumors
Elevation Oncology
Tubulis
Prostate cancer ADC acquired from Fortis breaks FibroGen's clinical losing streak
Fierce Biotech
Thu, 04/4/24 - 10:51 am
FibroGen
antibody-drug conjugate
prostate cancer
FG-3246
Genmab leans into hot ADC space with $1.8B ProfoundBio acquisition
BioSpace
Wed, 04/3/24 - 11:38 am
Genmab
M&A
ProfoundBio
antibody-drug conjugate
Ipsen joins ADC race via $900M biobuck deal with Sutro, chasing same target as Merck, Boehringer
Fierce Biotech
Tue, 04/2/24 - 11:34 am
Ipsen
antibody-drug conjugate
Sutro BioPharma
Biotheus, Hansoh Expand Partnership in $694M ADC Deal
BioSpace
Sun, 03/17/24 - 09:20 pm
Biotheus
Hansoh
antibody-drug conjugate
oncology
inflammatory diseases
ADC Biotech Tubulis Closes Upsized $138M Financing Round
BioSpace
Thu, 03/14/24 - 06:16 pm
Tubulis
funding
antibody-drug conjugate

Pages